4/A
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000276
EVP, Chief Development Officer sold 1,680 shares at $75.05 ($126,091)
- EVP, Chief Development Officer acquired 1,680 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Geary Richard S · EVP, Chief Development Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +775 | $60.89 | $47,190 | 60,432 | D |
| 2025-11-03 | Sale : show line 2 in the form 10b5-1 | −775 | $75.05 | $58,167 | 59,657 | D |
| 2025-11-03 | Exercise or conversion : show line 3 in the form 10b5-1 | +905 | $56.78 | $51,386 | 60,562 | D |
| 2025-11-03 | Sale : show line 4 in the form 10b5-1 | −905 | $75.05 | $67,924 | 59,657 | D |
| Open-market sales · 1,680 sh · avg $75.05 · $126,091 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-03 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −905 | 15,538 | D |
| 2025-11-03 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −775 | 19,101 | D |
Loading xslF345X05/edgardoc.xml…